[Evaluation of the treatment used in a case of autoimmune hemolytic anemia using the erythrophagocytosis functional test].
Biondi
C
C
Cotorruelo
C
C
Chernigoy
S
S
Racca
A
A
D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D002478:Cells, Cultured; D003298:Coombs Test; D003613:Danazol / Q000627:therapeutic use*; D004912:Erythrocytes; D005069:Evaluation Studies as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000150:complications / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000502:physiology*; D010587:Phagocytosis; D011237:Predictive Value of Tests; D011241:Prednisone / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D003613:Danazol; D011241:Prednisone
Evaluación del tratamiento utilizado en un caso de anemia hemolítica autoinmune por la prueba funcional de eritrofagocitosis.